# Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis

> **NCT01632540** · — · COMPLETED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 824 (actual)

## Conditions studied

- Perennial Allergic Rhinitis (PAR)

## Interventions

- **DRUG:** Beclomethasone Dipropionate (BDP) Nasal Aerosol

## Key facts

- **NCT ID:** NCT01632540
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-12
- **Final completion:** 2014-02
- **Target enrollment:** 824 (ACTUAL)
- **Last updated:** 2014-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01632540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01632540, "Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01632540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*